for Canada. (i) the Old Age Security Act and its regulations, and
for Canada the Assistant Deputy Minister, Tax Policy, of the Department of Finance or his successor;
for Canada. A decision by Canada following a review under the Investment Canada Act, R.S.C. 1985, c. 28 (1st Supp.),with respect to whether or not to permit an investment that is subject to review, is not subject to the dispute settlement provisions under Sections C (Settlement of Disputes Between an Investor and the Host Party) or D (State-to-State Dispute Settlement Procedures).
for Canada. The Minister of Indian Affairs and Northern Development 00 Xxxxxxxxxx Xxxxxx Xxxxxxxx (XX) X0X 0X0 Fax: (000) 000-0000 e-mail: xxxxxxx0@xxxx-xxxx.xx.xx And a copy to: Director General, Implementation Branch 00 Xxxxxxxxxx Xxxxxx Xxxxxxxx, (XX) X0X 0X0 Fax: (000) 000-0000 e-mail: xxxxxxx@xxxx-xxxx.xx.xx For the GCC(EI) and the CRA: The Grand Chief of the Cree Nation 0 Xxxxxxxxx Xxxx Xxxxxxx, Xxxxx Xxx (QC) J0Y 3B0 Fax: (000) 000-0000 e-mail: xxxxxxx@xxx.xx And a copy to: The Executive Director Grand Council of the Crees (Eeyou Istchee) Embassy of the Cree Nation 00 Xxxxxxxx Xxxxxx, Xxxxx 000 Xxxxxx (XX) X0X 0X0 Fax: (000) 000-0000 e-mail: xxxxxxxx@xxx.xx
for Canada. 1. With respect to mobile sources of NOx and VOC emissions, Canada shall control and reduce its emissions of NOx and VOC in accordance with the following obligations:
for Canada. 1. National Reductions In order to achieve, by 2010, the CWS for Ozone (65 ppb 8-hour average 4th highest averaged over 3 years), Canada intends to develop and implement further reductions of emissions of NOx and VOC.
for Canada. THE SUPPLY PRICES In the event that only Milestone 1 or Milestone 3 as specified in Appendix 3 of the License and Distribution Agreement as amended for Canada by Amendment Number 1 has been achieved, for Net Sales in each Commercial Year, the Supply Prices are to be calculated as *** percent (***%) of Net Selling Price. Immediately upon achievement of any additional Milestone listed in Appendix 3 of the License and Distribution Agreement as amended for Canada by Amendment Number 1, for Net Sales in each Commercial Year up to *** percent (*** %) of the Net Sales forecasts below, the Supply Prices are to be calculated as *** percent (*** %) of Net Selling Price. For Net Sales in each Commercial Year above *** percent (*** %) and up to *** percent (*** %) of the Net Sales forecasts below for that Commercial Year, *** percent (*** %) of the Net Selling Price shall be added to the Supply Price for the incremental Net Sales (for the avoidance of doubt, in respect of such incremental Net Sales, the Supply Price is *** percent (*** %) of the Net Selling Price). In respect of Net Sales in each Commercial Year above *** percent (*** %) of the Net Sales forecasts below for that Commercial Year, another *** percent (*** %) of the Net Selling Price shall be added to the Supply Price for the incremental Net Sales (for the avoidance of doubt, in respect of such incremental sales, the Supply Price is *** percent (*** %) of the Net Selling Price); provided, however, that BAYER is not entitled to a Supply Price of *** percent (*** %) according to Appendix 3, number 6 of the License and Distribution Agreement as amended for Canada by Amendment Number 1.
for Canada. The Food and Drugs Act and Medical Devices Regulations as amended from time to time; - the Canadian Electrical Code (as it relates to medical devices); - the Radiation Emitting Devices Act and Regulations as amended from time to time (as they relate to medical devices). It shall not, however, apply to the following products: - in vitro diagnostic medical devices; - devices incorporating, as an integral part, a substance which, if used separately, may be considered to be a medicinal product; - breast implants; - medical devices incorporating tissues of human or animal origin. However, medical devices incorporating tissues of animal origin and where the device is intended to come into contact with intact skin only, will be included within the scope of this Annex. Both Parties may decide by common agreement to extend the application of this Annex to include medical devices which were originally excluded from the Scope, during the Transition Period or the Operational Phase. Amendments to the Scope will be listed in Attachment 3.
for Canada. Greek citizens who accept to purchase full health care insurance, including insurance for hospitalization and repatriation, for the entire authorized period of stay, prior to their arrival in Canada;
